100 related articles for article (PubMed ID: 29217275)
1. Mechanistic understanding of ragweed pollen for oral vaccine delivery.
Park K
J Control Release; 2017 Dec; 268():427. PubMed ID: 29217275
[No Abstract] [Full Text] [Related]
2. Pollen grains as a novel microcarrier for oral delivery of proteins.
Lale SV; Gill HS
Int J Pharm; 2018 Dec; 552(1-2):352-359. PubMed ID: 30308271
[TBL] [Abstract][Full Text] [Related]
3. Ragweed pollen as an oral vaccine delivery system: Mechanistic insights.
Uddin MJ; Gill HS
J Control Release; 2017 Dec; 268():416-426. PubMed ID: 29054371
[TBL] [Abstract][Full Text] [Related]
4. Recent advancement of gelatin nanoparticles in drug and vaccine delivery.
Sahoo N; Sahoo RK; Biswas N; Guha A; Kuotsu K
Int J Biol Macromol; 2015 Nov; 81():317-31. PubMed ID: 26277745
[TBL] [Abstract][Full Text] [Related]
5. Influence of magnesium stearate on the physicochemical and pharmacodynamic characteristics of insulin-loaded Eudragit entrapped mucoadhesive microspheres.
Momoh MA; Kenechukwu FC; Nnamani PO; Umetiti JC
Drug Deliv; 2015; 22(6):837-48. PubMed ID: 24670092
[TBL] [Abstract][Full Text] [Related]
6. Overview on Therapeutic Applications of Microparticulate Drug Delivery Systems.
Bale S; Khurana A; Reddy AS; Singh M; Godugu C
Crit Rev Ther Drug Carrier Syst; 2016; 33(4):309-361. PubMed ID: 27910739
[TBL] [Abstract][Full Text] [Related]
7. Alginate microspheres of isoniazid for oral sustained drug delivery.
Rastogi R; Sultana Y; Aqil M; Ali A; Kumar S; Chuttani K; Mishra AK
Int J Pharm; 2007 Apr; 334(1-2):71-7. PubMed ID: 17113732
[TBL] [Abstract][Full Text] [Related]
8. Orchestrating immune responses: How size, shape and rigidity affect the immunogenicity of particulate vaccines.
Benne N; van Duijn J; Kuiper J; Jiskoot W; Slütter B
J Control Release; 2016 Jul; 234():124-34. PubMed ID: 27221070
[TBL] [Abstract][Full Text] [Related]
9. Quillaja saponaria extract as mucosal adjuvant with chitosan functionalized gold nanoparticles for mucosal vaccine delivery: stability and immunoefficiency studies.
Barhate G; Gautam M; Gairola S; Jadhav S; Pokharkar V
Int J Pharm; 2013 Jan; 441(1-2):636-42. PubMed ID: 23117021
[TBL] [Abstract][Full Text] [Related]
10. Development and characterization of guar gum nanoparticles for oral immunization against tuberculosis.
Kaur M; Malik B; Garg T; Rath G; Goyal AK
Drug Deliv; 2015 May; 22(3):328-34. PubMed ID: 24611942
[TBL] [Abstract][Full Text] [Related]
11. Formulation, characterization and optimization of hepatitis B surface antigen (HBsAg)-loaded chitosan microspheres for oral delivery.
Premaletha K; Licy CD; Jose S; Saraladevi A; Shirwaikar A; Shirwaikar A
Pharm Dev Technol; 2012; 17(2):251-8. PubMed ID: 21108582
[TBL] [Abstract][Full Text] [Related]
12. The intestinal uptake of particles and the implications for drug and antigen delivery.
O'Hagan DT
J Anat; 1996 Dec; 189 ( Pt 3)(Pt 3):477-82. PubMed ID: 8982819
[TBL] [Abstract][Full Text] [Related]
13. Nanoparticles and microparticles for drug and vaccine delivery.
Kreuter J
J Anat; 1996 Dec; 189 ( Pt 3)(Pt 3):503-5. PubMed ID: 8982823
[TBL] [Abstract][Full Text] [Related]
14. Eudragit® L100-coated mannosylated chitosan nanoparticles for oral protein vaccine delivery.
Xu B; Zhang W; Chen Y; Xu Y; Wang B; Zong L
Int J Biol Macromol; 2018 Jul; 113():534-542. PubMed ID: 29408613
[TBL] [Abstract][Full Text] [Related]
15. Novel bilayer dissolving microneedle arrays with concentrated PLGA nano-microparticles for targeted intradermal delivery: Proof of concept.
Vora LK; Donnelly RF; Larrañeta E; González-Vázquez P; Thakur RRS; Vavia PR
J Control Release; 2017 Nov; 265():93-101. PubMed ID: 29037785
[TBL] [Abstract][Full Text] [Related]
16. The allergens in ragweed pollen Physicochemical and immunologic studies on a purified fraction of the dialysate of ragweed, pollen.
RICHTER M; GRIFFITHS BW; ROSE B
J Immunol; 1961 Oct; 87():439-46. PubMed ID: 14492050
[No Abstract] [Full Text] [Related]
17. Alginate microspheres obtained by the spray drying technique as mucoadhesive carriers of ranitidine.
Szekalska M; Amelian A; Winnicka K
Acta Pharm; 2015 Mar; 65(1):15-27. PubMed ID: 25781701
[TBL] [Abstract][Full Text] [Related]
18. Cell-Mediated and Humoral Immune Responses to Bordetella pertussis Inactivated Whole-Cells Encapsulated Alginate Microspheres as a New Vaccine Candidate.
Dounighi NM; Shahcheraghi F; Razzaghi-Abyaneh M; Nofeli M; Zolfagharian H
Curr Pharm Biotechnol; 2017; 18(7):585-593. PubMed ID: 28814229
[TBL] [Abstract][Full Text] [Related]
19. New insights into ragweed pollen allergens.
Bordas-Le Floch V; Groeme R; Chabre H; Baron-Bodo V; Nony E; Mascarell L; Moingeon P
Curr Allergy Asthma Rep; 2015 Nov; 15(11):63. PubMed ID: 26383916
[TBL] [Abstract][Full Text] [Related]
20. Co-opting Moore's law: Therapeutics, vaccines and interfacially active particles manufactured via PRINT®.
DeSimone JM
J Control Release; 2016 Oct; 240():541-543. PubMed ID: 27423326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
